Blog
Gabriela Rosu, M.D., Vice President, Global Medical Affairs and Pharmacovigilance at Veristat, ...
download
Stay updated with Veristat's May 2025 FDA guidance and regulatory news, including new drug ...
The regulatory landscape for cell and gene therapies (CGTs) is shifting fast.
Case Study
Partner with Veristat to future-proof your early-phase rare disease trial with expert data ...
While the publishing journey can vary depending on your therapy’s requirements, Veristat’s ...
The FDA recently released a draft guidance on the use of multi-regional clinical trials (MRCTs) in ...
Data Monitoring Committees (DMCs) play a vital role in clinical trials by providing independent ...
A growing number of biotech firms are questioning their long-standing strategy of initiating ...
Fact Sheet
Accelerate your journey to regulatory approval with Veristat’s proven end-to-end marketing ...
